Tilray supports first human study evaluating cannabis to tackle side-effect caused by breast cancer treatment

The Nanaimo-based Tilray, Inc., said it has successfully imported medical cannabis into the U.S. for use in a clinical trial aimed at providing relief to people suffering from taxane-induced peripheral neuropathy.

Learn More